Securities Code: 301584 Securities Abbreviation: C&D New Medical Announcement No.: 2026-045
Shanghai C&D New Medical Technology Group Co., Ltd.
Announcement on Progress of Guarantees for Subsidiaries
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and are free from any false records, misleading statements, or material omissions.
Special Risk Warning:
Shanghai C&D New Medical Technology Group Co., Ltd. (hereinafter referred to as the "Company") and its holding subsidiaries have provided guarantees totaling an amount exceeding 100% of the Company's latest audited net assets. Guarantees for holding subsidiaries with an asset-liability ratio exceeding 70% are expected to reach 50% of the Company's latest audited net assets. The aforementioned guarantees are all for subsidiaries within the scope of the Company's consolidated financial statements. The financial risks are within the Company's controllable range. Investors are advised to pay close attention to the guarantee risks.
I. Overview of External Guarantees
According to the financial budget for 2026, combined with daily operations and business development needs, the Company and its subsidiaries within the consolidated scope (collectively referred to as the "Company") plan to apply for a comprehensive credit line of no more than 18 billion yuan from banks and other financial institutions in 2026. The validity period of the comprehensive credit line is from the date of approval by the Company's 2025 Annual Shareholders' Meeting to the date of the Company's 2026 Annual Shareholders' Meeting. For specific details, please refer to the relevant announcement disclosed by the Company on Juchao Information Network (http://www.cninfo.com.cn) on April 21, 2026.
Given that some of the credit lines are for the financing of the Company's holding subsidiaries, to ensure the smooth application for credit lines by the subsidiaries, the Company held the 14th meeting of the Third Board of Directors on April 17, 2026, and the 2025 Annual Shareholders' Meeting on May 11, 2026. The "Proposal on the Company's Guarantees for Subsidiaries in 2026" was deliberated and approved, agreeing that the Company will provide various credit financing guarantees for subsidiaries within the consolidated financial statements in 2026.
The total amount of guarantees for business development and operations will not exceed 9 billion yuan (including the current amount, the same below). Among them, the guarantee amount for subsidiaries with an asset-liability ratio exceeding 70% is 8 billion yuan, and the guarantee amount for subsidiaries with an asset-liability ratio below 70% is 1 billion yuan.
The above guarantee amount includes new guarantees and the extension or renewal of existing guarantees. Within the total guarantee amount, the Company's subsidiaries can adjust guarantee amounts among themselves and provide guarantees for newly established subsidiaries. When a subsidiary (credit line recipient) has an asset-liability ratio exceeding 70%, the required adjusted guarantee amount can only be obtained from other subsidiaries (credit line providers) with an asset-liability ratio also exceeding 70%. The validity period of the above guarantee amount is from the date of approval by the Company's 2025 Annual Shareholders' Meeting to the date of the Company's 2026 Annual Shareholders' Meeting. During the validity period, the guarantee amount can be used cyclically, and the actual total guarantee amount shall not exceed the approved guarantee amount.
The types of business covered by the comprehensive credit line include, but are not limited to, bank financing, bank acceptance bills, supply chain finance, and financial leasing. The specific guarantee methods, guarantee amounts, and guarantee periods for various financing credit lines and businesses shall be subject to the officially signed guarantee documents. For specific details, please refer to the relevant announcement disclosed by the Company on Juchao Information Network (http://www.cninfo.com.cn) on April 21, 2026.
II. Progress of This Guarantee
Recently, the Company and its holding subsidiaries have provided joint liability guarantees totaling 593.10 million yuan for the comprehensive credit lines applied for by Fujian Dermal Medical Industry Co., Ltd., C&D Dermal (Beijing) Medical Technology Co., Ltd., Beijing C&D Zhongtian Supply Chain Management Co., Ltd., D